Literature DB >> 17444274

Intrarenal renin-angiotensin system and counteracting protective mechanisms in angiotensin II-dependent hypertension.

K D Mitchell1, F T Botros, L G Navar.   

Abstract

It is now well accepted that alterations in kidney function, due either to primary renal disease or to inappropriate hormonal influences on the kidney, are a cardinal characteristic in all forms of hypertension, and lead to a reduced ability of the kidneys to excrete sodium and the consequent development of elevated arterial pressures. However, it is also apparent that many extrarenal factors are important contributors to altered kidney function and hypertension. Central to many hypertensinogenic processes is the inappropriate activation of the renin-angiotensin system (RAS) and its downstream consequences by various pathophysiologic mechanisms. There may also be derangements in arachidonic acid metabolites, endothelium derived factors such as nitric oxide and carbon monoxide, and various paracrine and neural systems that normally interact with or provide a counteracting balance to the actions of the RAS. Thus, when the capacity of the kidneys to maintain sodium balance and extracellular fluid volume within appropriate ranges is compromised, increases in arterial pressure become necessary to re-establish normal balance.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17444274     DOI: 10.1556/APhysiol.94.2007.1-2.5

Source DB:  PubMed          Journal:  Acta Physiol Hung        ISSN: 0231-424X


  5 in total

Review 1.  The complex interplay between cyclooxygenase-2 and angiotensin II in regulating kidney function.

Authors:  Torrance Green; Alexis A Gonzalez; Kenneth D Mitchell; L Gabriel Navar
Journal:  Curr Opin Nephrol Hypertens       Date:  2012-01       Impact factor: 2.894

2.  Increased angiotensinogen expression, urinary angiotensinogen excretion, and tissue injury in nonclipped kidneys of two-kidney, one-clip hypertensive rats.

Authors:  Weijian Shao; Kayoko Miyata; Akemi Katsurada; Ryousuke Satou; Dale M Seth; Carla B Rosales; Minolfa C Prieto; Kenneth D Mitchell; L Gabriel Navar
Journal:  Am J Physiol Renal Physiol       Date:  2016-05-18

3.  Interlobular Arteries From 2-Kidney, 1-Clip Goldblatt Hypertensive Rats' Exhibit-Impaired Vasodilator Response to Epoxyeicosatrienoic Acids.

Authors:  Alexandra Sporková; Rami N Reddy; John R Falck; John D Imig; Libor Kopkan; Janusz Sadowski; Luděk Červenka
Journal:  Am J Med Sci       Date:  2016-02-23       Impact factor: 2.378

4.  Pivotal role of angiotensin II receptor subtype 1A in the development of two-kidney, one-clip hypertension: study in angiotensin II receptor subtype 1A knockout mice.

Authors:  Ludek Cervenka; Ivana Vanecková; Zuzana Husková; Zdenka Vanourková; Michaela Erbanová; Monika Thumová; Petra Skaroupková; Martin Opocenský; Jan Malý; Vera Certíková Chábová; Vladimír Tesar; Marcela Bürgelová; Ondrej Viklický; Vladimír Teplan; Michal Zelízko; Herbert J Kramer; L Gabriel Navar
Journal:  J Hypertens       Date:  2008-07       Impact factor: 4.844

5.  Clinical characteristics of coronavirus disease 2019 (COVID-19) patients with hypertension on renin-angiotensin system inhibitors.

Authors:  Xian Zhou; Jingkang Zhu; Tao Xu
Journal:  Clin Exp Hypertens       Date:  2020-05-13       Impact factor: 1.749

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.